Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaNet Development Group | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PharmaNet Development Group

Jeffrey Freitag, M.D., senior vice president, PharmaNet Consulting, will also become chief medical officer of PharmaNet Development Group, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jeffrey Freitag, M.D., senior vice president, PharmaNet Consulting, will also become chief medical officer of PharmaNet Development Group, Inc. Dr. Freitag will be the senior medical representative for the company and provide guidance to physicians involved in designing and monitoring Phase I – Phase III trials. He will also continue to head PharmaNet’s team of regulatory and pharmaceutical consultants.

“Excellence in pharmaceutical science and medicine is critical to the success of PharmaNet and its clients. We are therefore very pleased that Dr. Jeffrey Freitag, an accomplished internist and nephrologist, will be serving in the role of CMO,” said Dr. Tom Newman, president of PharmaNet Development Group.

Dr. Freitag has worked in the pharmaceutical industry for more than 25 years in a variety of positions including vice president, clinical drug development at The Liposome Co., senior vice president of Medical Affairs at PharmaNet and most recently as vice president of R&D at Bone Care International before rejoining PharmaNet in 2006.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics